SignaBlok (United States)

Recent papers from SignaBlok (United States)

1. TREM-1-mediated modulation of innate immune response in acute and chronic inflammation: Effect of treatment timing and cell specificity on outcome 2223031The Journal of Immunology · 2026
2. B30-02 Evaluation of TREM-1 Therapy as a Medical Countermeasure for Inhalation Sulfur Mustard in Male Sprague Dawley RatsAmerican Journal of Respiratory and Critical Care Medicine · 2026
3. Abstract 2891: Specificity and timing of TREM-1 blockade initiation impact its therapeutic efficacy in cancerCancer Research · 2026
4. Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug ProductsThe AAPS Journal · 2026
5. TREM-1 inhibitor specificity and timing of treatment initiation can impact its therapeutic efficacy in cancer and inflammatory diseaseFrontiers in Oncology · 2025
6. TREM-1 and TREM-2 as therapeutic targets: clinical challenges and perspectivesFrontiers in Immunology · 2024
7. Inhibiting triggering receptor expressed on myeloid cells 1 signaling to ameliorate skin fibrosisJCI Insight · 2024
8. Increasing Access To Perinatal Mental Health Care: The Perinatal Psychiatry Access Program ModelHealth Affairs · 2024
9. Altered IL-7 signaling in CD4+ T cells from patients with visceral leishmaniasisPLoS neglected tropical diseases · 2024
10. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2PLoS Pathogens · 2023
11. Non‐Invasive prenatal testing with rolling circle amplification: Real‐world clinical experience in a non‐molecular laboratoryJournal of Clinical Laboratory Analysis · 2023
12. Inhibition of TREM-2 Markedly Suppresses Joint Inflammation and Damage in Experimental ArthritisInternational Journal of Molecular Sciences · 2022
13. A Sociotechnical Systems Framework for Performance-Based Design for Fire SafetyFire Technology · 2022
14. Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor OutcomesFrontiers in Oncology · 2021
15. SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationaleBiochimie · 2021
16. SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale2021
17. The effect of cue type on directive-following in children with moderate to severe autism spectrum disorderAugmentative and Alternative Communication · 2021
18. Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) Contributes to Bordetella pertussis Inflammatory PathologyInfection and Immunity · 2021
19. Evaluation of the Legal Framework for Building Fire Safety Regulations in SpainBuildings · 2021
20. Efficient Computation of the Generalized Parabolic Cylinder Function DistributionJournal of Geolocation Geo-information and Geo-intelligence · 2021